While rare, secondary cancers after CAR T-cell therapy have been reported, leading the FDA to mandate boxed warnings on all approved therapies. In a first, targeted therapy was used to treat a T-cell ...

The sarcoma and follicular lymphoma drug tazemetostat (Tazverik) is being voluntarily pulled from the US and all other markets due to the risk of secondary hematologic malignancies, according to ...

“Full House” star Dave Coulier on Tuesday revealed he was diagnosed with a second type of cancer just months after beating stage 3 Non-Hodgkin’s lymphoma. During an appearance on the “Today Show,” ...

A little over a year after being diagnosed with non-Hodgkin lymphoma, Dave Coulier announced exclusively on the "TODAY" show that he is undergoing treatment for an unrelated tongue cancer. Subscribe ...

The EMA has backed new and expanded uses for multiple cancer drugs, signaling a push toward biomarker-driven, earlier-line ...

Comparing Hodgkin and Non-Hodgkin Lymphoma Mortality Between Latin America and the United States From 2008 to 2019: The Need of Regional-Based Lymphoma Registries Hodgkin lymphoma (HL) is classified ...

This is read by an automated voice. Please report any issues or inconsistencies here. Beloved “Full House” star Dave Coulier announced Tuesday that he was diagnosed in October with a form of tongue ...